Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage Heterogeneity and Efferocytosis: Beyond the M1/M2 Dichotomy. | Circ Res | 2024 | 38236949 | PubTator, text mining | PubMed |
| Targeting TIGIT for cancer immunotherapy: recent advances and future directions. | Biomark Res | 2024 | 38229100 | PubTator, text mining | PubMed |
| Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma. | BMC Med | 2024 | 38229080 | PubTator, text mining | PubMed |
| Proteomic analysis reveals LRPAP1 as a key player in the micropapillary pattern metastasis of lung adenocarcinoma. | Heliyon | 2024 | 38226250 | PubTator, text mining | PubMed |
| Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators. | Mol Cancer | 2024 | 38217023 | PubTator, text mining | PubMed |
| Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies. | J Biomed Sci | 2024 | 38217016 | PubTator, text mining | PubMed |
| Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity. | J Med Chem | 2024 | 38197367 | PubTator, text mining | PubMed |
| Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. | Biomark Res | 2024 | 38185636 | PubTator, text mining | PubMed |
| Efficient 3D imaging and pathological analysis of the human lymphoma tumor microenvironment using light-sheet immunofluorescence microscopy. | Theranostics | 2024 | 38164148 | PubTator, text mining | PubMed |
| GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy. | Biol Direct | 2024 | 38163861 | PubTator, text mining | PubMed |
| Novel Substrate Prediction for the TAM Family of RTKs Using Phosphoproteomics and Structure-Based Modeling. | ACS Chem Biol | 2024 | 38159292 | PubTator, text mining | PubMed |
| Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma. | Hepatol Int | 2024 | 38159218 | PubTator, text mining | PubMed |
| Encrypted federated learning for secure decentralized collaboration in cancer image analysis. | Med Image Anal | 2024 | 38104402 | PubTator, text mining | PubMed |
Tumor-related exosomal circ_0001715 promotes lung adenocarcinoma cell proliferation and metastasis via enhancing M2 macrophage polarization by regulating triggering receptor expressed on myeloid cells-2. | Thorac Cancer | 2024 | 38087801 | PubTator, text mining | PubMed |
| Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. | Noncoding RNA Res | 2024 | 38075202 | PubTator, text mining | PubMed |
| Critical role of CD206+ macrophages in promoting a cDC1-NK-CD8 T cell anti-tumor immune axis. | bioRxiv | 2024 | 37961697 | PubTator, text mining | PubMed |
| Recent application of CRISPR-Cas12 and OMEGA system for genome editing. | Mol Ther | 2024 | 37952084 | PubTator, text mining | PubMed |
| Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells. | Mol Cancer Ther | 2024 | 37802502 | PubTator, text mining | PubMed |
| TAM-Hijacked Immunoreaction Rescued by Hypoxia-Pathway-Intervened Strategy for Enhanced Metastatic Cancer Immunotherapy. | Small | 2024 | 37752692 | PubTator, text mining | PubMed |
| Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions. | Genes Dis | 2024 | 37692522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=11